ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,746.35
0.02%
Dow Jones
42,427.81
0.60%
US Dollar vs MXN
19.6836
0.31%
Brent Oil
71.53
0.82%
Bitcoin
66,244.87
1.63%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Ekso Bionics Holdings Inc (EKSO)

  7. Ekso Bionics Holdings Inc (EKSO) Noticias

EKSO

Ekso Bionics (EKSO)

Ekso Bionics Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:EKSO
FechaHoraFuenteTítuloSímboloCompañía
12/09/202415:29Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:EKSOEkso Bionics Holdings Inc
03/09/202415:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EKSOEkso Bionics Holdings Inc
30/08/202416:30Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:EKSOEkso Bionics Holdings Inc
29/08/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EKSOEkso Bionics Holdings Inc
29/08/202421:42GlobeNewswire Inc.Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public OfferingNASDAQ:EKSOEkso Bionics Holdings Inc
28/08/202408:25Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EKSOEkso Bionics Holdings Inc
20/08/202407:00GlobeNewswire Inc.Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego PersonalNASDAQ:EKSOEkso Bionics Holdings Inc
29/07/202416:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EKSOEkso Bionics Holdings Inc
29/07/202415:55Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EKSOEkso Bionics Holdings Inc
29/07/202415:39Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:EKSOEkso Bionics Holdings Inc
29/07/202415:05GlobeNewswire Inc.Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024NASDAQ:EKSOEkso Bionics Holdings Inc
26/07/202415:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:EKSOEkso Bionics Holdings Inc
22/07/202407:00GlobeNewswire Inc.Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024NASDAQ:EKSOEkso Bionics Holdings Inc
25/06/202407:00GlobeNewswire Inc.Ekso Bionics Announces Research Partnership with Shepherd CenterNASDAQ:EKSOEkso Bionics Holdings Inc
17/06/202415:05GlobeNewswire Inc.Ekso Bionics Appoints Deborah Lafer Scher to its Board of DirectorsNASDAQ:EKSOEkso Bionics Holdings Inc
14/06/202417:08Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EKSOEkso Bionics Holdings Inc
03/06/202415:58Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:EKSOEkso Bionics Holdings Inc
10/05/202407:00GlobeNewswire Inc.Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew PinskyNASDAQ:EKSOEkso Bionics Holdings Inc
29/04/202415:05GlobeNewswire Inc.Ekso Bionics Announces First Quarter 2024 Financial ResultsNASDAQ:EKSOEkso Bionics Holdings Inc
22/04/202407:00GlobeNewswire Inc.Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024NASDAQ:EKSOEkso Bionics Holdings Inc
12/04/202407:00GlobeNewswire Inc.Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego PersonalNASDAQ:EKSOEkso Bionics Holdings Inc
04/03/202415:14Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EKSOEkso Bionics Holdings Inc
04/03/202415:05GlobeNewswire Inc.Ekso Bionics Reports Record Annual Revenue of $18.3 MillionNASDAQ:EKSOEkso Bionics Holdings Inc
26/02/202407:00GlobeNewswire Inc.Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024NASDAQ:EKSOEkso Bionics Holdings Inc
11/01/202407:00GlobeNewswire Inc.Ekso Bionics Announces $4.6 Million Registered Direct OfferingNASDAQ:EKSOEkso Bionics Holdings Inc
08/01/202415:05GlobeNewswire Inc.Ekso Bionics Launches GaitCoach Software for EksoNRNASDAQ:EKSOEkso Bionics Holdings Inc
04/01/202416:05GlobeNewswire Inc.Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:EKSOEkso Bionics Holdings Inc
12/12/202307:00GlobeNewswire Inc.Ekso Bionics Receives CMS Coding Approval for Ekso Indego PersonalNASDAQ:EKSOEkso Bionics Holdings Inc
16/11/202315:05GlobeNewswire Inc.Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29NASDAQ:EKSOEkso Bionics Holdings Inc
02/11/202315:01GlobeNewswire Inc.Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego PersonalNASDAQ:EKSOEkso Bionics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:EKSO

Su Consulta Reciente

USOTC
BLQC
BlockQuarry (PK)
LSE
RC85
Citi Fun 25
LSE
FP07
Citi Fun 24
COIN
BINEUR
AMEX
SSO
ProShares Ultra S&P 500
NASDAQ
FEGIKX
Market Strength Allocati...
USOTC
WOBK
Woodsboro Bank (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados